Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Zfp410 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZFP410 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of ZFP410 mRNA and Ethinyl Estradiol results in decreased expression of ZNF410 mRNA | CTD | PMID:15953391 and PMID:17108234 | 17alpha-ethynylestradiol | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP410 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp410 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP410 mRNA | CTD | PMID:21570461 | 2-methylcholine | affects expression | ISO | ZNF410 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ZNF410 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ZFP410 mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZFP410 mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA | CTD | PMID:32699268 | acrylamide | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of ZNF410 mRNA | CTD | PMID:32763439 | alpha-pinene | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA | CTD | PMID:32699268 | arsenous acid | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of ZFP410 mRNA | CTD | PMID:35676786 | benzo[a]pyrene | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ZFP410 mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZFP410 mRNA and bisphenol A results in increased expression of ZNF410 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ZFP410 mRNA | CTD | PMID:33221593 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ZFP410 gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA | CTD | PMID:28628672 | cadmium atom | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA | CTD | PMID:35301059 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of ZFP410 mRNA | CTD | PMID:33453195 | cadmium dichloride | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA | CTD | PMID:35301059 | carbamazepine | affects expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ZNF410 mRNA | CTD | PMID:25979313 | cisplatin | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ZNF410 mRNA | CTD | PMID:27594783 | cyclosporin A | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ZNF410 mRNA | CTD | PMID:20106945 and PMID:25562108 | dexamethasone | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of ZFP410 mRNA | CTD | PMID:35676786 | dibutyl phthalate | decreases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP410 mRNA | CTD | PMID:21266533 | epoxiconazole | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ZFP410 mRNA | CTD | PMID:35436446 | flusilazole | affects expression | ISO | Zfp410 (Mus musculus) | 6480464 | flusilazole affects the expression of ZFP410 mRNA | CTD | PMID:21195148 | folic acid | decreases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP410 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | ISO | ZNF410 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of ZNF410 protein | CTD | PMID:37730182 | geraniol | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | geraniol results in increased expression of ZNF410 mRNA | CTD | PMID:27683099 | hexaconazole | affects expression | ISO | Zfp410 (Mus musculus) | 6480464 | hexaconazole affects the expression of ZFP410 mRNA | CTD | PMID:21195148 | indometacin | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA | CTD | PMID:28628672 | methotrexate | decreases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of ZNF410 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ZNF410 mRNA | CTD | PMID:23649840 | ozone | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA more ... | CTD | PMID:32699268 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zfp410 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ZNF410 mRNA | CTD | PMID:19159669 | resveratrol | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF410 mRNA | CTD | PMID:23557933 | sodium arsenite | decreases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZNF410 mRNA | CTD | PMID:28595984 | sunitinib | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ZNF410 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | Zfp410 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ZFP410 mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ZFP410 mRNA | CTD | PMID:34492290 | triadimefon | affects expression | ISO | Zfp410 (Mus musculus) | 6480464 | triadimefon affects the expression of ZFP410 mRNA | CTD | PMID:21195148 | urethane | increases expression | ISO | ZNF410 (Homo sapiens) | 6480464 | Urethane results in increased expression of ZNF410 mRNA | CTD | PMID:28818685 | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of ZFP410 gene | CTD | PMID:31079544 | zinc atom | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | ZNF410 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA | CTD | PMID:18593933 | |